本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

45.63
+0.48001.06%
盘后45.630.00000.00%17:51 EDT
成交量:78.90万
成交额:3,567.65万
市值:34.81亿
市盈率:60.84
高:45.93
开:45.21
低:44.36
收:45.15
52周最高:49.12
52周最低:18.26
股本:7,629.42万
流通股本:3,524.44万
量比:1.05
换手率:2.24%
股息:- -
股息率:- -
每股收益(TTM):0.7500
每股收益(LYR):0.7500
净资产收益率:11.73%
总资产收益率:7.18%
市净率:6.13
市盈率(LYR):60.84

数据加载中...

2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/24

重要事件披露

Form 8-K - Current report
2026/01/14

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/28

重要事件披露

Form 8-K - Current report
2025/10/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities